NCT07629206 2026-06-05Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSenseĀ® Cryoablation (ChoICE Trial)IceCure Medical Ltd.Phase NA Not yet recruiting400 enrolled